TRIB3 and acute promyelocytic leukemia: In this study, we verified the hypothesis that the metabolic stress sensor TRIB3 collaborates with the oncoprotein PML-RARα to inhibit PPARγ activity and subsequently cause dyslipidemia in newly diagnosed APL patients.